HealthyNCT06601686
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
A study testing Transcranial electrical stimulation (TES) and Transcranial electrical stimulation with temporal interference (TES-TI) in people with Healthy, run by University of Wisconsin, Madison at 1 site in United States.
Trial summary
The goal of this clinical trial is to learn whether brain stimulation technology can help people reach a meditative state quickly and easily without years of meditation training. Read more about this study
- Who is it for?
- Ages 18 to 80 yearsHealthy volunteers can take part
- Conditions the study is for
- Healthy
- What is being tested?
- Transcranial electrical stimulation (TES) and Transcranial electrical stimulation with temporal interference (TES-TI)
- Type of treatment
- Medical device
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 22 participants
- Where
- 1 siteUnited States
- Study dates
- 8 Jan 2025to Jan 2028
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 80 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Adults, ages 18 to 80 of any identified gender
- Medically healthy
- English-speaking (able to provide consent and complete questionnaires)
- Healthy adults with a consistent meditation practice
- Citizen or legal resident
Who cannot join
- Any current or past history of neurological disorders or acquired neurological disease (e.g. stroke, traumatic brain injury), including intracranial lesions
- Any current or past history of bipolar disorder and/or hypomania
- Any current or past history of psychosis
- History of head trauma resulting in prolonged loss of consciousness; or a history of greater than 3 grade I concussions
- Current history of poorly controlled headaches including intractable or poorly controlled migraines
- Any systemic illness or unstable medical condition that may cause a medical emergency in case of a provoked seizure (cardiac malformation, cardiac dysrhythmia, asthma, etc.)
Show all 19Show fewer
- History of fainting spells of unknown or undetermined etiology that might constitute seizures
- History of seizures, diagnosis of epilepsy, history of abnormal (epileptiform) EEG, or family history of treatment resistant epilepsy with the exception of a single seizure of benign etiology (e.g. febrile seizures) in the judgment of a board-certified neurologist
- Possible pregnancy. All female participants of child-bearing age are required to have a pregnancy test
- Any metal in the brain, skull or head
- Any contraindications to MRI
- Any medical devices or implants (i.e. cardiac pacemaker, medication infusion pump, cochlear implant, vagal nerve stimulator, dental implants (this includes a permanent retainer)) unless otherwise approved by the responsible MD
- Substance abuse or dependence within the past six months
- Any medication that may alter seizure threshold i.e., ADHD stimulants (Adderall, amphetamine); Tricyclic/atypical antidepressants (Amitriptyline, Dioxepine, Imipramine Maprotiline, Nortriptyline, Bupropion); Antipsychotics (Chlorpromazine, Clozapine), Bronchodilators (theophylline, aminophylline); Antibiotics (fluoroquinolones, imipenem, penicillin, cephalosporins, metronidazole, isoniazid); Antiviral (Valacyclovir, Ritonavir); OTC (Diphenhydramine)
- Claustrophobia (a fear of small or closed places)
- Back problems that would prevent lying flat for up to two hours
- Motion sickness
- Any hair braid, dreadlocks, hair pieces, or extensions which cannot be taken out or adjusted to permit comfortable and comprehensive participation before the MRI scans and/or stimulation sessions
- Any head coverings or headdress that participant feels uncomfortable removing for the purposes of the MRI scans and/or stimulation session
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
University of Wisconsin
Madison, Wisconsin, 53719
Simone Bruno, 608-209-4108, sbruno3@wisc.edu
Melanie Boly, MD, PhD
About this study
Official title: Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study
The goal of this clinical trial is to learn whether brain stimulation technology can help people reach a meditative state quickly and easily without years of meditation training. The researchers want to see if this will help people distance themselves from their thoughts and feeling, and if this will lead to improvements in openness and wellbeing the same way meditation can.
Participants will:
- Complete questionnaires
- Perform a guided meditation task (The Bell Task)
- Wear a high density electrocochleography (hdEEG) cap
- Undergo brain stimulation
- Perform cognitive tasks
Read the detailed description
This study is being done to evaluate the relative effectiveness of distinct types of non-invasive brain stimulation - NIBS (TES-TI and TES) on subjective ego disengagement and cortical activity in experienced meditators.
Phase 1 (registered to this record) involves administering 2 distinct types of deep brain stimulation techniques to a small sample (N=22) of experienced meditators to determine which type of neuromodulation, when focused on disruption of posteromedial cortex (PMC) activity, most robustly facilitates positive ego-disengagement compared to sham; and to discern the region of the PMC where disruption is most effective in achieving ego disengagement.
Phase 2 (registered to a separate record, NCT06601699) will use the most effective stimulation and PMC parameters to meditation naïve healthy adults.
- Conditions
- Healthy
- Being tested
- Transcranial electrical stimulation (TES), Transcranial electrical stimulation with temporal interference (TES-TI), Sham stimulation
- Keywords
- meditation, brain stimulation
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Transcranial electrical stimulation (TES)Device
TES uses specific electrode arrangement patterns to selectively stimulate the brain. Participants will wear an hdEEG (high density electroencephalography) cap which will allow intermittent periods of stimulation from TES.
Transcranial electrical stimulation with temporal interference (TES-TI)Device
TES-TI uses specific electrode arrangement patterns to selectively stimulate the brain. Participants will wear an hdEEG (high density electroencephalography) cap which will allow intermittent periods of stimulation from TES-TI.
Sham stimulationDevice
TES-TI sham includes receiving stimulation from all electrodes at the same frequency. Sham TES will include administration of transcranial random noise stimulation (tRNS), random oscillating current. It will also include periods with no stimulation and a ramping up period followed by no stimulation.
| Study group | Role | What they receive |
|---|---|---|
| Stimulation | Experimental | Participants will undergo sham, TES or TES-TI stimulation while completing cognitive assessments. Receives: Device: Transcranial electrical stimulation (TES); Device: Transcranial electrical stimulation with temporal interference (TES-TI); Device: Sham stimulation |
What is being measured
The primary outcome is the main question the study is designed to answer.
Ego-Disengagement scale
Ego-disengagement will be measured using the bell task. This meditation task consists of five "bell trials." During each trial, subjects will be asked to focus on the sound of a bell until it fades, then on the space left empty by the faded sound, resting free from thoughts as long as possible (meditation condition). Afterward, subjects will respond to a few questions designed to assess their level of ego-disengagement during the trials. This is a five-question form that asks subjects to rate, on a scale from 0-4, the degree to which they were perceiving something, imagining something, thinking about themselves, or thinking about something during the previous bell trial and then to rate the valence of their emotional state during the trial from 1 (highly negative) to 6 (highly positive).
Measured: Data collected at one study visit (anytime up to 2 weeks on study)
Cortical activity - change in gamma band power
Gamma band power will be measured with hdEEG during stimulation. A decrease indicates greater level of ego disengagement.
Measured: Data collected at one study visit (anytime up to 2 weeks on study)
Cortical activity - change in alpha band power
Alpha band power will be measured with hdEEG during stimulation. An increase indicates greater level of ego disengagement.
Measured: Data collected at one study visit (anytime up to 2 weeks on study)
Secondary outcomes (31)
Big Five Aspects Scale (BFAS)
This is a 44-item inventory that measures five different personality traits by asking subjects to respond to various items (e.g., I see myself as someone who is talkative) on a scale from 1 (disagree strongly) to 5 (agree strongly).
Measured: Data collected at one study visit (anytime up to 2 weeks on study)
Fulfilled Life Scale (FLS)
This is a 32-item inventory that asks subjects to respond to various items (e.g., When I look back on my life, I feel deep inner contentment) on a scale from 1 (does not apply at all) to 6 (applies completely) and is designed to assess subjects' feelings of having lived a full life.
Measured: Data collected at one study visit (anytime up to 2 weeks on study)
Patient-Reported Outcomes Measurement Information System (PROMIS) Anxiety
This is an 8-item inventory asking subjects to rate from 1-5 the frequency with which they have experienced components of anxiety in the last seven days. Higher scores reflect greater anxiety.
Measured: Data collected at one study visit (anytime up to 2 weeks on study)
PROMIS Depression
This is an 8-item inventory asking subjects to rate from 1-5 the frequency with which they have experienced components of depression in the last seven days. Higher scores reflect greater depression.
Measured: Data collected at one study visit (anytime up to 2 weeks on study)
Perceived Stress Scale (PSS)
This is a 10-item inventory asking subjects to rate from 0-4 the frequency with which they have felt various kinds of stress in the last month. Participants rate each item on a scale ranging from "Never (0)" to "Very often (4)". Seven of the items with positive statements are scored in reverse. As the scores obtained from the scale increase, the perceived stress level of the person increases. Scores range from 0-40.
Measured: Data collected at one study visit (anytime up to 2 weeks on study)
Questionnaire for Eudaimonic Well-Being (QEWB)
This is a 21-item inventory asking subjects to rate from 0-4 the extent to which they agree with various statements designed to assess their overall well-being. Scores range from 0-84 with higher scores indicating higher levels of well-being.
Measured: Data collected at one study visit (anytime up to 2 weeks on study)
Psychological Wellbeing Scale (PWB)
The PWB Scale is a tool designed to measure various aspects of an individual's psychological well-being. The scale consists of 18 items and assesses six key dimensions of well-being: Autonomy - The ability to make independent decisions and resist social pressures; Environmental Mastery -The capacity to manage one's life and surrounding environment effectively; Personal Growth - A sense of continued development and realization of one's potential; Positive Relations with Others -The presence of meaningful, trusting relationships; Purpose in Life - Having goals and a sense of direction in life; Self-Acceptance - A positive attitude towards oneself and one's past life. There are three items per each dimension. Each item is rated on a scale from 1 (strongly disagree) to 7 (strongly agree), higher scores indicate higher wellbeing.
Measured: Data collected at one study visit (anytime up to 2 weeks on study)
IQSS Flourishing Measure
The Human Flourishing Measures is designed to assess various domains of human well-being and flourishing. Developed by the Human Flourishing Program at Harvard University, this measure aims to provide a comprehensive understanding of an individual's overall well-being, across different domains such as, health, life satisfaction, purpose, close relationships. The questionnaire consists of 12 items, rated from 0 (Strongly disagree) to 10 (Strongly agree). High scores imply that people perceive themselves very positively in terms of human flourishing.
Measured: Data collected at one study visit (anytime up to 2 weeks on study)
Metacognitive Processes of Decentering Scale (MPoD)
The MPoD is designed to measure the ability to decenter from internal experiences. Decentering involves viewing thoughts and feelings as temporary and objective events in the mind, rather than as reflections of the self. Items are scored from 1 (never or very rarely) to 5 (very often or always) for a total range of scores from 15-75 where higher scores indicate higher levels of engagement with trait-like metacognitive processes of decentering.
Measured: Data collected at one study visit (anytime up to 2 weeks on study)
Experiences Questionnaire (EQ)
This 20-item self-report measure assesses trait levels of decentering and rumination. Decentering refers to the ability to view one's thoughts and feelings as temporary, objective events rather than reflections of the self. It is a key component of mindfulness and is often developed through meditation practices. The component Rumination includes items that measure the tendency to dwell on negative thoughts and feelings. For example, items might ask about the frequency of repetitive, negative thinking. Items are scored from 1 (never) to 5 (all the time) where higher scores indicate indicate higher decentering and rumination.
Measured: Data collected at one study visit (anytime up to 2 weeks on study)
Self-Reflection Insight Scale (SRIS)
The SRIS is a psychometric tool designed to measure two critical components of self-awareness: self-reflection and insight. It provides a reliable means of assessing individuals' tendencies to engage in introspection and their ability to gain clear understanding from such introspection. Participants respond to each item using a Likert scale ranging from 1 (strongly disagree) to 6 (strongly agree). Higher scores indicate self-awareness.
Measured: Data collected at one study visit (anytime up to 2 weeks on study)
Non-Attachment Scale (NAS)
NAS is designed to assess the extent to which individuals experience nonattachment in their daily lives. The NAS consists of 30 items that participants rate based on their agreement from 1 (strongly disagree) to 6 (strongly agree). The items are designed to capture various aspects of nonattachment, such as the ability to let go of thoughts and emotions, and the tendency to experience life without excessive clinging or aversion. Higher scores indicate more non-attachment.
Measured: Data collected at one study visit (anytime up to 2 weeks on study)
Non-Attachment to Self Scale (NTS)
NTS is a psychological measure designed to assess the degree to which individuals are not fixated on self-related concepts, thoughts, and feelings. It captures the ability to interact with these self-related elements flexibly and without trying to control them. It is a single factor, 7-item scale, where each item is scored from 1 (Strongly Disagree) to 7 (Strongly Agree). Higher scores indicate more non-attachment to self.
Measured: Data collected at one study visit (anytime up to 2 weeks on study)
Five Facet Mindfulness Questionnaire (FFMQ)
FFMQ is a comprehensive self-report instrument designed to assess mindfulness across five distinct dimensions. The FFMQ consists of 39 items, divided into five subscales, each representing a different facet of mindfulness: observing, describing, acting with awareness, nonjudging of inner experience, nonreactivity to inner experience. Participants respond to each item using a Likert scale ranging from 1 (never or very rarely true) to 5 (very often or always true). Higher scores on the FFMQ reflects a higher level of mindfulness (a better outcome).
Measured: Data collected at one study visit (anytime up to 2 weeks on study)
Drexel Defusion Scale (DDS)
DDS is a psychometric instrument developed to measure the construct of defusion, which refers to the ability to achieve psychological distance from internal experiences such as thoughts and feelings. Participants respond to each item using a six-point Likert scale ranging from 0 (not at all) to 5 (very much), for a total possible range of scores from 0-50, higher scores indicate increased ability to defuse.
Measured: Data collected at one study visit (anytime up to 2 weeks on study)
Relationship Questionnaire (RQ)
RQ is a self-report instrument designed to assess various dimensions of interpersonal relationship styles. The RQ consists of 4 items, each describing a specific relationship style. Participants rate each item on a 7-point Likert scale, ranging from "1 = Strongly Disagree" to "7 = Strongly Agree."
Measured: Data collected at one study visit (anytime up to 2 weeks on study)
UCLA Loneliness Scale (ULS)
ULS is a widely used tool designed to measure an individual's subjective feelings of loneliness and social isolation. The scale consists of 20 items. Each item is rated on a 4-point Likert scale ranging from 1 (Never) to 4 (Often). Some items are reverse-scored to control for response bias. The total score ranges from 20 to 80, with higher scores indicating greater levels of loneliness.
Measured: Data collected at one study visit (anytime up to 2 weeks on study)
Social Connectedness Scale (SCS)
SCS, developed by Richard M. Lee and Steven B. Robbins in 1995, is a self-report questionnaire designed to measure the extent to which individuals feel connected to others in their social environment. The scale assesses feelings of closeness and belongingness, which are crucial for psychological well-being. The scale consists of 20 items. Each item is rated on a Likert scale ranging from 1 (strongly disagree) to 6 (strongly agree). Higher scores indicate a greater sense of social connectedness, while lower scores suggest feelings of social isolation or disconnection.
Measured: Data collected at one study visit (anytime up to 2 weeks on study)
Attachment Style Questionnaire (ASQ)
ASQ is a self-report measure designed to assess adult attachment styles. This questionnaire helps identify how individuals typically think, feel, and behave in close relationships. The ASQ consists of 40 items rated on 6-point Likert Scale (1 Totally disagree - 6 Totally Agree). It measures five dimensions of attachment, that is, confidence, discomfort with closeness, need for approval, preoccupation with relationship, relationship as secondary.
Measured: Data collected at one study visit (anytime up to 2 weeks on study)
Emotional Intelligence Scale (EIS)
EIS is designed to measure the ability to identify, assess, and manage the emotions of oneself, others, and groups. The EIS consists of 33 items. Participants rate each item on a 5-point Likert scale ranging from 1 (strongly disagree) to 5 (strongly agree). Higher scores indicate higher emotional intelligence.
Measured: Data collected at one study visit (anytime up to 2 weeks on study)
Barratt Impulsiveness Scale (BIS-11)
BIS-11 is a widely used self-report measure designed to assess the personality/behavioral construct of impulsiveness. The BIS-11 consists of 30 items, each rated on a 4-point Likert scale ranging from 1 (rarely/never) to 4 (almost always/always).
The BIS-11 measures three primary dimensions of impulsiveness:
- Attentional Impulsiveness: Difficulty focusing attention and a tendency to make quick decisions.
- Motor Impulsiveness: Acting on the spur of the moment and a lack of perseverance.
- Non-Planning Impulsiveness: A lack of forethought or consideration of future consequences.
Each of these dimensions is further broken down into subscales, providing a detailed profile of an individual's impulsivity traits. The total score ranges from 30 to 120, with higher scores indicating higher levels of impulsiveness.
Measured: Data collected at one study visit (anytime up to 2 weeks on study)
Dickman Impulsivity Inventory (DII)
DII is a self-report measure designed to assess two distinct types of impulsivity: functional impulsivity and dysfunctional impulsivity. Functional Impulsivity is characterized by the tendency to act quickly and effectively in situations where such behavior is beneficial.
Dysfunctional Impulsivity involves acting with less forethought than most people, leading to negative outcomes. The DII consists of 23 items that are true or false statements. Each true statement is scored as 1. The scores for each subscale (functional impulsivity and dysfunctional impulsivity) are summed, with higher scores indicating higher levels of functional or dysfunctional impulsivity.
Measured: Data collected at one study visit (anytime up to 2 weeks on study)
Vividness of Visual Imagery Questionnaire (VVIQ)
VVIQ is a tool developed to assess the vividness of an individual's visual imagination. Items are scored on a 5-point Likert Scale from 1 (no image at all) to 5 (Perfectly clear and as vivid as normal vision). The questionnaire includes scenarios such as visualizing a friend's face, a rising sun, and other common scenes to gauge the vividness of the mental images. Higher scores indicate more vivid visual imagery.
Measured: Data collected at one study visit (anytime up to 2 weeks on study)
Implicit Association Task: Response Time
IAT is a psychological tool designed to measure the strength of automatic associations between mental representations of objects or concepts. The IAT typically involves categorizing words or images that appear on a computer screen into different groups as quickly as possible. For example, participants might be asked to categorize words as either "pleasant" or "unpleasant" and images as either "young" or "old." The speed at which participants categorize the items is crucial. Faster response times indicate stronger implicit associations between the categories being tested.
Measured: Data collected at one study visit (anytime up to 2 weeks on study)
Implicit Association Task: Accuracy Reported as the Number of Misclassifications
IAT is a psychological tool designed to measure the strength of automatic associations between mental representations of objects or concepts. The IAT typically involves categorizing words or images that appear on a computer screen into different groups as quickly as possible. For example, participants might be asked to categorize words as either "pleasant" or "unpleasant" and images as either "young" or "old." Participants complete 8 blocks of 24 trials each, consisting of two groups of 4 incongruent and 4 congruent blocks. Within each group of blocks, the first trial serves as a practice trial.
Measured: Data collected at one study visit (anytime up to 2 weeks on study)
Implicit Association Task: D-Score
IAT is a psychological tool designed to measure the strength of automatic associations between mental representations of objects or concepts. The IAT typically involves categorizing words or images that appear on a computer screen into different groups as quickly as possible. For example, participants might be asked to categorize words as either "pleasant" or "unpleasant" and images as either "young" or "old."
Reported here is the the D-score that measures the standardized difference between the average response times for congruent and incongruent pairings, adjusted for the number of errors. It typically ranges from -2 to 2. A score near zero indicates selfless processing of fear. Positive scores are expected to represent identification with fear. Conversely, negative scores are expected to represent negative self-referential evaluation of fear.
Measured: Data collected at one study visit (anytime up to 2 weeks on study)
Rapid Discrimination Task: Speed
The Rapid Discrimination Task is a cognitive task used to assess an individual's ability to quickly and accurately distinguish between different stimuli. Participants are presented with a series of stimuli, which can vary in attributes such as shape, color, size, or emotional expression. The task requires participants to make quick decisions about the stimuli, often under time constraints.
Both the speed and accuracy of responses are measured to assess perceptual and cognitive abilities. For the Rapid Discrimination Task, two black and white geometric shapes one next to the other are presented using Eprime. In some slides, the two shapes will be identical and in others they will differ by one line or outside edge of the shape being slightly different than the other. The participant is instructed to press the 'S' button on the keyboard if they are the same or the 'L' button if they are different. This will repeat for up to 25 minutes until the task ends.
Measured: Data collected at one study visit (anytime up to 2 weeks on study)
Rapid Discrimination Task: Accuracy
The Rapid Discrimination Task is a cognitive task used to assess an individual's ability to quickly and accurately distinguish between different stimuli. Participants are presented with a series of stimuli, which can vary in attributes such as shape, color, size, or emotional expression. The task requires participants to make quick decisions about the stimuli, often under time constraints.
Both the speed and accuracy of responses are measured to assess perceptual and cognitive abilities. For the Rapid Discrimination Task, two black and white geometric shapes one next to the other are presented using Eprime. In some slides, the two shapes will be identical and in others they will differ by one line or outside edge of the shape being slightly different than the other. The participant is instructed to press the 'S' button on the keyboard if they are the same or the 'L' button if they are different. This will repeat for up to 25 minutes until the task ends.
Measured: Data collected at one study visit (anytime up to 2 weeks on study)
Spontaneous Mentation Task
Participants with eyes open or closed will be prompted by a beep to report the last thing that was going through their mind (image, thought, feeling, emotion …) just before the sound. After this open-ended report, participants will also be asked to rate on a VAS scale (e.g., from 0 to 5) their awareness, some quality aspects of their mentation content (e.g, how thought-like or image-like it was; or the degree of cognitive effort).
[will the VAS score be reported?]
Measured: Data collected at one study visit (anytime up to 2 weeks on study)
Automatic Emotion Regulation Task
The automatic emotion regulation (AER) task is designed to investigate how individuals modulate their emotional responses without conscious effort. In this task, participants are exposed to various emotional stimuli, in this experiment image, which are typically categorized as positive (e.g., a puppy or a sunset), negative (e.g., the image of a natural disaster or of a person in distress), or neutral (e.g., the photo of a chair or of a building). These stimuli are presented rapidly to minimize conscious regulation efforts.
During the task, functional MRI data will be recorded. The goal is to measure how effectively participants can automatically regulate their emotional reactions. Data analysis focuses on comparing responses across different emotional conditions to infer the efficiency of automatic emotion regulation.
Participants will rate on a VAS scale (from 1 to 10) the intensity of the emotional content evoked by each picture, higher numbers are more intense.
Measured: Data collected at one hour MRI visit (scheduled within 2 weeks on study)
Resting State Task
Participants are simply asked to rest quietly, awake but relaxed, to record brain activity without any external stimuli influencing it.
The signal measured within each voxel is based on the blood-oxygen-level-dependent (BOLD) contrast, which reflects changes in blood flow and oxygenation associated with neural activity.
While resting state activity can help the interpretation of different task states, it will be mainly evaluated as a measure in itself to assess baseline brain functional organization of the participants.
Measured: Data collected at one hour MRI visit (scheduled within 2 weeks on study)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Sep 2024
- Study start8 Jan 2025
- Primary completionJan 2027 (estimated)
- Study completionJan 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for HealthyStudies of the same condition, open and under way.
- More trials run by University of Wisconsin, MadisonThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Basic science
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 22 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Wisconsin, Madison
- Sponsor type
- University, hospital or other
- Collaborators
- Tiny Blue Dot Foundation
- Responsible party
- Sponsor
- Investigators
- Melanie Boly, MD, PhD, Principal investigator, University of Wisconsin, Madison
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06601686
- Sponsor's protocol ID
- 2023-0613
- Other IDs
- A535100, Protocol Version 4/10/26
- Status last verified
- May 2026
- First submitted
- 10 Sep 2024
- Last updated
- 26 May 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- Yes
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 26 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study
- ClinicalTrials.gov ID
- NCT06601686
- Acronym / sponsor ID
- 2023-0613
- Conditions
- Healthy
- Keywords
- meditation, brain stimulation
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 22 participants (estimated)
- Lead sponsor
- University of Wisconsin, MadisonUniversity, hospital or other
- Collaborators
- Tiny Blue Dot Foundation
- Study start
- 8 Jan 2025 (actual)
- Primary completion
- Jan 2027 (estimated)
- Study completion
- Jan 2028 (estimated)
- First posted
- 19 Sep 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this clinical trial is to learn whether brain stimulation technology can help people reach a meditative state quickly and easily without years of meditation training. The researchers want to see if this will help people distance themselves from their thoughts and feeling, and if this will lead to improvements in openness and wellbeing the same way meditation can.
Participants will:
- Complete questionnaires
- Perform a guided meditation task (The Bell Task)
- Wear a high density electrocochleography (hdEEG) cap
- Undergo brain stimulation
- Perform cognitive tasks
Detailed description
This study is being done to evaluate the relative effectiveness of distinct types of non-invasive brain stimulation - NIBS (TES-TI and TES) on subjective ego disengagement and cortical activity in experienced meditators.
Phase 1 (registered to this record) involves administering 2 distinct types of deep brain stimulation techniques to a small sample (N=22) of experienced meditators to determine which type of neuromodulation, when focused on disruption of posteromedial cortex (PMC) activity, most robustly facilitates positive ego-disengagement compared to sham; and to discern the region of the PMC where disruption is most effective in achieving ego disengagement.
Phase 2 (registered to a separate record, NCT06601699) will use the most effective stimulation and PMC parameters to meditation naïve healthy adults.
Study design
- Primary purpose
- Basic science
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Stimulation | Experimental | Device: Transcranial electrical stimulation (TES), Device: Transcranial electrical stimulation with temporal interference (TES-TI), Device: Sham stimulationParticipants will undergo sham, TES or TES-TI stimulation while completing cognitive assessments. |
Who may qualify
- Ages
- 18 to 80 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- Adults, ages 18 to 80 of any identified gender
- Medically healthy
- English-speaking (able to provide consent and complete questionnaires)
- Healthy adults with a consistent meditation practice
- Citizen or legal resident
Key exclusion criteria (19 listed)
- Any current or past history of neurological disorders or acquired neurological disease (e.g. stroke, traumatic brain injury), including intracranial lesions
- Any current or past history of bipolar disorder and/or hypomania
- Any current or past history of psychosis
- History of head trauma resulting in prolonged loss of consciousness; or a history of greater than 3 grade I concussions
- Current history of poorly controlled headaches including intractable or poorly controlled migraines
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Transcranial electrical stimulation (TES)TES uses specific electrode arrangement patterns to selectively stimulate the brain. Participants will wear an hdEEG (high density electroencephalography) cap which will allow intermittent periods of stimulation from TES. | Device | Stimulation |
| Transcranial electrical stimulation with temporal interference (TES-TI)TES-TI uses specific electrode arrangement patterns to selectively stimulate the brain. Participants will wear an hdEEG (high density electroencephalography) cap which will allow intermittent periods of stimulation from TES-TI. | Device | Stimulation |
| Sham stimulationTES-TI sham includes receiving stimulation from all electrodes at the same frequency. Sham TES will include administration of transcranial random noise stimulation (tRNS), random oscillating current. It will also include periods with no stimulation and a ramping up period followed by no stimulation. | Device | Stimulation |
Primary outcome
Ego-Disengagement scale
Time frame: Data collected at one study visit (anytime up to 2 weeks on study)
Ego-disengagement will be measured using the bell task. This meditation task consists of five "bell trials." During each trial, subjects will be asked to focus on the sound of a bell until it fades, then on the space left empty by the faded sound, resting free from thoughts as long as possible (meditation condition). Afterward, subjects will respond to a few questions designed to assess their level of ego-disengagement during the trials. This is a five-question form that asks subjects to rate, on a scale from 0-4, the degree to which they were perceiving something, imagining something, thinking about themselves, or thinking about something during the previous bell trial and then to rate the valence of their emotional state during the trial from 1 (highly negative) to 6 (highly positive).
Cortical activity - change in gamma band power
Time frame: Data collected at one study visit (anytime up to 2 weeks on study)
Gamma band power will be measured with hdEEG during stimulation. A decrease indicates greater level of ego disengagement.
Cortical activity - change in alpha band power
Time frame: Data collected at one study visit (anytime up to 2 weeks on study)
Alpha band power will be measured with hdEEG during stimulation. An increase indicates greater level of ego disengagement.
31 secondary outcomes
Big Five Aspects Scale (BFAS)
Time frame: Data collected at one study visit (anytime up to 2 weeks on study)
Fulfilled Life Scale (FLS)
Time frame: Data collected at one study visit (anytime up to 2 weeks on study)
Patient-Reported Outcomes Measurement Information System (PROMIS) Anxiety
Time frame: Data collected at one study visit (anytime up to 2 weeks on study)
PROMIS Depression
Time frame: Data collected at one study visit (anytime up to 2 weeks on study)
Perceived Stress Scale (PSS)
Time frame: Data collected at one study visit (anytime up to 2 weeks on study)
Questionnaire for Eudaimonic Well-Being (QEWB)
Time frame: Data collected at one study visit (anytime up to 2 weeks on study)
Psychological Wellbeing Scale (PWB)
Time frame: Data collected at one study visit (anytime up to 2 weeks on study)
IQSS Flourishing Measure
Time frame: Data collected at one study visit (anytime up to 2 weeks on study)
Metacognitive Processes of Decentering Scale (MPoD)
Time frame: Data collected at one study visit (anytime up to 2 weeks on study)
Experiences Questionnaire (EQ)
Time frame: Data collected at one study visit (anytime up to 2 weeks on study)
Self-Reflection Insight Scale (SRIS)
Time frame: Data collected at one study visit (anytime up to 2 weeks on study)
Non-Attachment Scale (NAS)
Time frame: Data collected at one study visit (anytime up to 2 weeks on study)
Non-Attachment to Self Scale (NTS)
Time frame: Data collected at one study visit (anytime up to 2 weeks on study)
Five Facet Mindfulness Questionnaire (FFMQ)
Time frame: Data collected at one study visit (anytime up to 2 weeks on study)
Drexel Defusion Scale (DDS)
Time frame: Data collected at one study visit (anytime up to 2 weeks on study)
Relationship Questionnaire (RQ)
Time frame: Data collected at one study visit (anytime up to 2 weeks on study)
UCLA Loneliness Scale (ULS)
Time frame: Data collected at one study visit (anytime up to 2 weeks on study)
Social Connectedness Scale (SCS)
Time frame: Data collected at one study visit (anytime up to 2 weeks on study)
Attachment Style Questionnaire (ASQ)
Time frame: Data collected at one study visit (anytime up to 2 weeks on study)
Emotional Intelligence Scale (EIS)
Time frame: Data collected at one study visit (anytime up to 2 weeks on study)
Barratt Impulsiveness Scale (BIS-11)
Time frame: Data collected at one study visit (anytime up to 2 weeks on study)
Dickman Impulsivity Inventory (DII)
Time frame: Data collected at one study visit (anytime up to 2 weeks on study)
Vividness of Visual Imagery Questionnaire (VVIQ)
Time frame: Data collected at one study visit (anytime up to 2 weeks on study)
Implicit Association Task: Response Time
Time frame: Data collected at one study visit (anytime up to 2 weeks on study)
Implicit Association Task: Accuracy Reported as the Number of Misclassifications
Time frame: Data collected at one study visit (anytime up to 2 weeks on study)
Implicit Association Task: D-Score
Time frame: Data collected at one study visit (anytime up to 2 weeks on study)
Rapid Discrimination Task: Speed
Time frame: Data collected at one study visit (anytime up to 2 weeks on study)
Rapid Discrimination Task: Accuracy
Time frame: Data collected at one study visit (anytime up to 2 weeks on study)
Spontaneous Mentation Task
Time frame: Data collected at one study visit (anytime up to 2 weeks on study)
Automatic Emotion Regulation Task
Time frame: Data collected at one hour MRI visit (scheduled within 2 weeks on study)
Resting State Task
Time frame: Data collected at one hour MRI visit (scheduled within 2 weeks on study)
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 May 2026.
- Neuromodulation-assisted Ego-disengagement: the NEURO-EGO Study Stage 2Link provided by the sponsor.
- Individual participant dataSharing planned: No
Related trials for Healthy
Recruiting
THE EFFECTS OF GAME-BASED EXERCISE PROGRAMS
Physical Activity, Body Image
Not yet recruitingPhase 1
A Phase I Study of GLR2053 Tablets in Chinese Healthy Adult Participants
Atopic Dermatitis
Recruiting
Colon-delivered Riboflavin and Gut Microbiota Composition
Microbiome Dysbiosis, Gut Health
Not yet recruiting
Neuroergonomic Analysis of a Brain-Computer Interface Device (BCI)
Healthy Volunteers - Male and Female
RecruitingPhase 1
First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
Healthy Volunteer, Atopic Dermatitis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Melanie Boly, MD, PhD principal investigator
University of Wisconsin, Madison
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Transcranial electrical stimulation (TES) and Transcranial electrical stimulation with temporal interference (TES-TI) in people with Healthy, run by University of Wisconsin, Madison at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 19 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 26 May 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Simone Bruno (608-209-4108, sbruno3@wisc.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Ego-Disengagement scale (time frame: Data collected at one study visit (anytime up to 2 weeks on study)). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 May 2026.